| Ident. | Authors (with country if any) | Title |
|---|
| 000020 (2014) |
Barbara. Tilley [États-Unis] ; Nancy. Lapelle [États-Unis] ; Christopher. Goetz [États-Unis] ; Glenn. Stebbins [États-Unis] | Using cognitive pretesting in scale development for Parkinson's disease: the Movement Disorder Society Unified Parkinson's Disease Rating Scale (MDS-UPDRS) example. |
| 000031 (2014) |
Sotirios. Parashos [États-Unis] ; Sheng Luo ; Kevin. Biglan [États-Unis] ; Ivan Bodis ; Bo He ; Grace. Liang [États-Unis] ; G Ross [États-Unis] ; Barbara. Tilley ; Lisa. Shulman [États-Unis] | Measuring disease progression in early Parkinson disease: the National Institutes of Health Exploratory Trials in Parkinson Disease (NET-PD) experience. |
| 000037 (2014) |
José Baizabal [États-Unis] ; Joseph Jankovic [États-Unis] | Deep brain stimulation of the subthalamic nucleus for peripherally induced parkinsonism. |
| 000042 (2013) |
Peter. Lewitt [États-Unis] ; Babak Boroojerdi ; Erwin Surmann ; Werner Poewe | Rotigotine transdermal system for long-term treatment of patients with advanced Parkinson's disease: results of two open-label extension studies, CLEOPATRA-PD and PREFER. |
| 000043 (2013) |
Karen Marder [États-Unis] ; Yian Gu ; Shirley Eberly ; Caroline. Tanner ; Nikolaos Scarmeas ; David Oakes ; Ira Shoulson | Relationship of Mediterranean diet and caloric intake to phenoconversion in Huntington disease. |
| 000044 (2013) |
E Dorsey [États-Unis] ; Christopher. Beck [États-Unis] ; Kristin Darwin [États-Unis] ; Paige Nichols [États-Unis] ; Alicia. Brocht [États-Unis] ; Kevin. Biglan [États-Unis] ; Ira Shoulson [États-Unis] | Natural history of Huntington disease. |
| 000045 (2013) |
Glenn. Stebbins [États-Unis] ; Christopher. Goetz ; David. Burn ; Joseph Jankovic [États-Unis] ; Tien. Khoo ; Barbara. Tilley | How to identify tremor dominant and postural instability/gait difficulty groups with the movement disorder society unified Parkinson's disease rating scale: comparison with the unified Parkinson's disease rating scale. |
| 000049 (2013) |
Ju Kang ; David. Irwin ; Alice. Chen ; Andrew Siderowf ; Chelsea Caspell ; Christopher. Coffey ; Teresa Walig ; Peggy Taylor ; Sarah Pan ; Mark Frasier ; Kenneth Marek ; Karl Kieburtz ; Danna Jennings ; Tanya Simuni ; Caroline. Tanner ; Andrew Singleton ; Arthur. Toga ; Sohini Chowdhury ; Brit Mollenhauer ; John. Trojanowski ; Leslie. Shaw | Association of cerebrospinal fluid β-amyloid 1-42, T-tau, P-tau181, and α-synuclein levels with clinical features of drug-naive patients with early Parkinson disease. |
| 000053 (2012) |
Michael. Okun [États-Unis] ; Bruno. Gallo ; George Mandybur ; Jonathan Jagid ; Kelly. Foote ; Fredy. Revilla ; Ron Alterman ; Joseph Jankovic [États-Unis] ; Richard Simpson ; Fred Junn ; Leo Verhagen ; Jeff. Arle ; Blair Ford ; Robert. Goodman ; R Stewart ; Stacy Horn ; Gordon. Baltuch ; Brian. Kopell ; Frederick Marshall ; Delea Peichel ; Rajesh Pahwa ; Kelly. Lyons ; Alexander. Tröster ; Jerrold. Vitek ; Michele Tagliati | Subthalamic deep brain stimulation with a constant-current device in Parkinson's disease: an open-label randomised controlled trial. |
| 000058 (2012) |
Lawrence. Elmer [États-Unis] ; Erwin Surmann ; Babak Boroojerdi ; Joseph Jankovic [États-Unis] | Long-term safety and tolerability of rotigotine transdermal system in patients with early-stage idiopathic Parkinson's disease: a prospective, open-label extension study. |
| 000063 (2012) |
Jordan. Elm [États-Unis] | Design innovations and baseline findings in a long-term Parkinson's trial: the National Institute of Neurological Disorders and Stroke Exploratory Trials in Parkinson's Disease Long-Term Study-1. |
| 000076 (2011) |
Connie Marras [Canada] ; Michael. Mcdermott ; Ken Marek ; Paula Rochon ; Gary Naglie ; Caroline. Tanner ; Alice Rudolph ; Ira Shoulson ; Anthony. Lang | Predictors of time to requiring dopaminergic treatment in 2 Parkinson's disease cohorts. |
| 000082 (2011) |
Min Shi [États-Unis] ; Joshua Bradner ; Aneeka. Hancock ; Kathryn. Chung ; Joseph. Quinn ; Elaine. Peskind ; Douglas Galasko ; Joseph Jankovic [États-Unis] ; Cyrus. Zabetian ; Hojoong. Kim ; James. Leverenz ; Thomas. Montine ; Carmen Ginghina ; Un Kang ; Kevin. Cain ; Yu Wang ; Jan Aasly ; David Goldstein ; Jing Zhang | Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression. |
| 000083 (2011) |
Olivier Rascol [France] ; Cheryl. Fitzer ; Robert Hauser ; Joseph Jankovic [États-Unis] ; Anthony Lang ; J Langston ; Eldad Melamed ; Werner Poewe ; Fabrizio Stocchi ; Eduardo Tolosa ; Eli Eyal ; Yoni. Weiss ; C Olanow | A double-blind, delayed-start trial of rasagiline in Parkinson's disease (the ADAGIO study): prespecified and post-hoc analyses of the need for additional therapies, changes in UPDRS scores, and non-motor outcomes. |
| 000094 (2010) |
Rodger. Elble [États-Unis] ; Oksana Suchowersky ; Stephanie Shaftman ; William. Weiner ; Peng Huang ; Barbara Tilley | Impact of belief in neuroprotection on therapeutic intervention in Parkinson's disease. |
| 000098 (2010) |
William. Marks [États-Unis] ; Raymond. Bartus ; Joao Siffert ; Charles. Davis ; Andres Lozano ; Nicholas Boulis ; Jerrold Vitek ; Mark Stacy ; Dennis Turner ; Leonard Verhagen ; Roy Bakay ; Raymond Watts ; Barton Guthrie ; Joseph Jankovic [États-Unis] ; Richard Simpson ; Michele Tagliati ; Ron Alterman ; Matthew Stern ; Gordon Baltuch ; Philip. Starr ; Paul. Larson ; Jill. Ostrem ; John Nutt ; Karl Kieburtz ; Jeffrey. Kordower ; C Olanow | Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial. |
| 000100 (2010) |
Zhen Hong [États-Unis] ; Min Shi ; Kathryn. Chung ; Joseph. Quinn ; Elaine. Peskind ; Douglas Galasko ; Joseph Jankovic [États-Unis] ; Cyrus. Zabetian ; James. Leverenz ; Geoffrey Baird ; Thomas. Montine ; Aneeka. Hancock ; Hyejin Hwang ; Catherine Pan ; Joshua Bradner ; Un. Kang ; Poul. Jensen ; Jing Zhang | DJ-1 and alpha-synuclein in human cerebrospinal fluid as biomarkers of Parkinson's disease. |
| 000107 (2009) |
Bernard Ravina [États-Unis] ; Jordan Elm ; Richard Camicioli ; Peter. Como ; Laura Marsh ; Joseph Jankovic [États-Unis] ; Daniel Weintraub | The course of depressive symptoms in early Parkinson's disease. |
| 000126 (2009) |
Joseph Jankovic [États-Unis] | Atomoxetine for freezing of gait in Parkinson disease. |
| 000128 (2009) |
C Olanow [États-Unis] ; Olivier Rascol ; Robert Hauser ; Paul. Feigin ; Joseph Jankovic [États-Unis] ; Anthony Lang ; William Langston ; Eldad Melamed ; Werner Poewe ; Fabrizio Stocchi ; Eduardo Tolosa | A double-blind, delayed-start trial of rasagiline in Parkinson's disease. |
| 000140 (2008) |
Christopher. Goetz [États-Unis] ; Barbara. Tilley ; Stephanie. Shaftman ; Glenn. Stebbins ; Stanley Fahn ; Pablo Martinez ; Werner Poewe ; Cristina Sampaio ; Matthew. Stern ; Richard Dodel ; Bruno Dubois ; Robert Holloway ; Joseph Jankovic [États-Unis] ; Jaime Kulisevsky ; Anthony. Lang ; Andrew Lees ; Sue Leurgans ; Peter. Lewitt ; David Nyenhuis ; C Olanow ; Olivier Rascol ; Anette Schrag ; Jeanne. Teresi ; Jacobus. Van ; Nancy Lapelle | Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. |
